Group One Trading’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-48,700
| Closed | -$239K | – | 9186 |
|
|
2021
Q3 | $239K | Sell |
48,700
-700
| -1% | -$3.4K | ﹤0.01% | 4987 |
|
|
2021
Q2 | $261K | Buy |
49,400
+20,900
| +73% | +$108K | ﹤0.01% | 4936 |
|
|
2021
Q1 | $137K | Buy |
28,500
+28,200
| +9,400% | +$147K | ﹤0.01% | 5368 |
|
|
2020
Q4 | $1K | Sell |
300
-15,000
| -98% | -$64.2K | ﹤0.01% | 6387 |
|
|
2020
Q3 | $63K | Buy |
15,300
+14,200
| +1,291% | +$54.9K | ﹤0.01% | 4501 |
|
|
2020
Q2 | $3K | Sell |
1,100
-100
| -8% | -$294 | ﹤0.01% | 5525 |
|
|
2020
Q1 | $3K | Sell |
1,200
-63,500
| -98% | -$285K | ﹤0.01% | 4929 |
|
|
2019
Q4 | $245K | Buy |
64,700
+62,500
| +2,841% | +$299K | ﹤0.01% | 3025 |
|
|
2019
Q3 | $11K | Sell |
2,200
-54,500
| -96% | -$336K | ﹤0.01% | 4584 |
|
|
2019
Q2 | $352K | Buy |
56,700
+8,600
| +18% | +$49.5K | ﹤0.01% | 2453 |
|
|
2019
Q1 | $342K | Buy |
48,100
+32,000
| +199% | +$288K | ﹤0.01% | 2256 |
|
|
2018
Q4 | $137K | Sell |
16,100
-5,700
| -26% | -$74.1K | ﹤0.01% | 2965 |
|
|
2018
Q3 | $436K | Buy |
21,800
+400
| +2% | +$9.39K | ﹤0.01% | 2397 |
|
|
2018
Q2 | $553K | Sell |
21,400
-18,200
| -46% | -$504K | ﹤0.01% | 2213 |
|
|
2018
Q1 | $946K | Sell |
39,600
-12,700
| -24% | -$400K | 0.01% | 1568 |
|
|
2017
Q4 | $1.77M | Buy |
52,300
+23,800
| +84% | +$665K | 0.01% | 1272 |
|
|
2017
Q3 | $603K | Buy |
28,500
+27,500
| +2,750% | +$504K | 0.01% | 1933 |
|
|
2017
Q2 | $17K | Buy |
+1,000
| New | +$16.5K | ﹤0.01% | 4020 |
|
Group One Trading's ADMS Position: Q4 2021 in Review
Group One Trading sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 16,483 shares — an estimated $81K sold.
Group One Trading first reported a position in ADMS in Q4 2015 and held it in 13 quarters. The position peaked at $794K in Q3 2017. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.
- Group One Trading reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Group One Trading sold 16,483 Adamas Pharmaceuticals shares in Q4 2021, an estimated $81K.
- Group One Trading first reported a position in Adamas Pharmaceuticals in Q4 2015 and held it in 13 quarters.
- Group One Trading's Adamas Pharmaceuticals position peaked at $794K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.
Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.